<DOC>
	<DOCNO>NCT02357966</DOCNO>
	<brief_summary>This study evaluate maximum safe dose true human monoclonal antibody , 514G3 , treatment patient Staphylococcus Aureus bacteremia . Preliminary evidence efficacy evaluate well . Patients receive 514G3 plus antibiotic placebo plus antibiotic approximately 3 1 ratio .</brief_summary>
	<brief_title>A Study Safety Efficacy 514G3 Subjects Hospitalized With Bacteremia Due Staphylococcus Aureus</brief_title>
	<detailed_description />
	<mesh_term>Bacteremia</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>1 . One blood culture positive staphylococcus aureus within 2 day initiate treatment 514G3 . 2 . Temperature ≥ 38.0°C 3 . Age ≥18 , male female subject . 4 . Adequate renal function , define serum creatinine ≤ 2 time upper limit normal ( ULN ) . 5 . Adequate hepatic function 6 . Adequate bone marrow function 7 . For woman childbearing potential ( WOCBP ) , negative serum pregnancy test result Screening . 8 . Signed date institutional review board ( IRB ) / Ethics Committee ( EC ) approve informed consent protocolspecific screening procedure perform . 9 . Expected survival least 2 month . 1 . Polymicrobial bacteremia . 2 . Known suspected osteomyelitis meningitis . 3 . Patients mechanically ventilated result pulmonary infection time screen . Mechanical ventilation reason , trauma , acceptable . 4 . Presence removable infection source ( e.g. , intravascular line , abscess , prosthesis ) remove debrided within 3 day randomization . 5 . Definite possible leftsided endocarditis , Modified Duke Criteria , base screen echocardiogram . Subjects suspect rightsided endocarditis permit . 6 . Need emergent valve surgery time screening , and/or presence decompensated heart failure cardiogenic shock . 7 . Dementia alter mental status would prohibit understanding rendering informed consent . 8 . Infection human immunodeficiency virus ( HIV ) CD4 count &lt; 200 cells/mm3 . 9 . Subjects history hypersensitivity compound similar chemical biologic composition 514G3 component formulation . 10 . Women pregnant breastfeeding .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Staph</keyword>
	<keyword>antibody</keyword>
</DOC>